216 related articles for article (PubMed ID: 35349706)
1. Oxidative stress-CBP axis modulates MOB1 acetylation and activates the Hippo signaling pathway.
Jin J; Zhang L; Li X; Xu W; Yang S; Song J; Zhang W; Zhan J; Luo J; Zhang H
Nucleic Acids Res; 2022 Apr; 50(7):3817-3834. PubMed ID: 35349706
[TBL] [Abstract][Full Text] [Related]
2. LATS1 K751 acetylation blocks activation of Hippo signalling and switches LATS1 from a tumor suppressor to an oncoprotein.
Yang S; Xu W; Liu C; Jin J; Li X; Jiang Y; Zhang L; Meng X; Zhan J; Zhang H
Sci China Life Sci; 2022 Jan; 65(1):129-141. PubMed ID: 33945069
[TBL] [Abstract][Full Text] [Related]
3. MOB1 Mediated Phospho-recognition in the Core Mammalian Hippo Pathway.
Couzens AL; Xiong S; Knight JDR; Mao DY; Guettler S; Picaud S; Kurinov I; Filippakopoulos P; Sicheri F; Gingras AC
Mol Cell Proteomics; 2017 Jun; 16(6):1098-1110. PubMed ID: 28373298
[TBL] [Abstract][Full Text] [Related]
4. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
5. Kindlin-2 Inhibits the Hippo Signaling Pathway by Promoting Degradation of MOB1.
Song J; Wang T; Chi X; Wei X; Xu S; Yu M; He H; Ma J; Li X; Du J; Sun X; Wang Y; Zhan J; Zhang H
Cell Rep; 2019 Dec; 29(11):3664-3677.e5. PubMed ID: 31825843
[TBL] [Abstract][Full Text] [Related]
6. Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control.
Kulaberoglu Y; Lin K; Holder M; Gai Z; Gomez M; Assefa Shifa B; Mavis M; Hoa L; Sharif AAD; Lujan C; Smith ESJ; Bjedov I; Tapon N; Wu G; Hergovich A
Nat Commun; 2017 Sep; 8(1):695. PubMed ID: 28947795
[TBL] [Abstract][Full Text] [Related]
7. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
[TBL] [Abstract][Full Text] [Related]
8. RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer.
Yang H; Hu J; Chen J; Chen Z; Jiao F; Cui J; Quan M; Wang L
Med Oncol; 2020 Aug; 37(9):84. PubMed ID: 32780197
[TBL] [Abstract][Full Text] [Related]
9. Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells.
Xiang YC; Peng P; Liu XW; Jin X; Shen J; Zhang T; Zhang L; Wan F; Ren YL; Yu QQ; Zhao HZ; Si Y; Liu Y
Acta Pharmacol Sin; 2022 Jun; 43(6):1568-1580. PubMed ID: 34522004
[TBL] [Abstract][Full Text] [Related]
10. Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease-free survival in individuals with non-small cell lung cancer.
Ando N; Tanaka K; Otsubo K; Toyokawa G; Ikematsu Y; Ide M; Yoneshima Y; Iwama E; Inoue H; Ijichi K; Tagawa T; Nakanishi Y; Okamoto I
Thorac Cancer; 2020 Oct; 11(10):2830-2839. PubMed ID: 32841529
[TBL] [Abstract][Full Text] [Related]
11. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.
Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB
J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353
[TBL] [Abstract][Full Text] [Related]
12. The Ethyl acetate extract from Celastrus orbiculatus suppresses non-small-cell lung cancer by activating Hippo signaling and inhibiting YAP nuclear translocation.
Jin F; Ni X; Yu S; Jiang X; Shi X; Zhou J; Mao D; Wang H; Liu Y; Wu F
Phytomedicine; 2023 Jun; 114():154761. PubMed ID: 37028249
[TBL] [Abstract][Full Text] [Related]
13. EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1.
Ando T; Arang N; Wang Z; Costea DE; Feng X; Goto Y; Izumi H; Gilardi M; Ando K; Gutkind JS
Commun Biol; 2021 Nov; 4(1):1237. PubMed ID: 34725466
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Protein Interactions by
Xiong S; Couzens AL; Kean MJ; Mao DY; Guettler S; Kurinov I; Gingras AC; Sicheri F
Mol Cell Proteomics; 2017 Jun; 16(6):1111-1125. PubMed ID: 28373297
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
16. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H
J Biol Chem; 2021; 296():100400. PubMed ID: 33571521
[TBL] [Abstract][Full Text] [Related]
17. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein.
Li C; Srivastava RK; Elmets CA; Afaq F; Athar M
Biochem Biophys Res Commun; 2013 Sep; 438(4):607-12. PubMed ID: 23942117
[TBL] [Abstract][Full Text] [Related]
18. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
[TBL] [Abstract][Full Text] [Related]
19. Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer.
Vahid S; Thaper D; Gibson KF; Bishop JL; Zoubeidi A
Sci Rep; 2016 Aug; 6():31842. PubMed ID: 27555231
[TBL] [Abstract][Full Text] [Related]
20. Liquid-Liquid Phase Separation of DDR1 Counteracts the Hippo Pathway to Orchestrate Arterial Stiffening.
Liu J; Wang J; Liu Y; Xie SA; Zhang J; Zhao C; Zhou Y; Pang W; Yao W; Peng Q; Wang X; Zhou J
Circ Res; 2023 Jan; 132(1):87-105. PubMed ID: 36475898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]